[Response and prognosis of neoadjuvant dose-dense or standard schedule chemotherapy with anthracyclines and taxanes for Luminal B breast cancer].
Zhonghua Yi Xue Za Zhi
; 97(44): 3466-3470, 2017 Nov 28.
Article
in Zh
| MEDLINE
| ID: mdl-29275580
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Anthracyclines
/
Neoadjuvant Therapy
/
Taxoids
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
Zh
Year:
2017
Type:
Article